Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

ABSTRACT: scRNAseq of human prolactinomas

PROVIDER: PRJNA1058601 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR27376408.fastq.gz	Fastqsanger.gz
	SRR27376409.fastq.gz	Fastqsanger.gz
	SRR27376410.fastq.gz	Fastqsanger.gz
	SRR27376411.fastq.gz	Fastqsanger.gz
	SRR27376412.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 6

Similar Datasets

microRNAs associated with bromocriptine-treated prolactinomas

2010-09-02 | GSE23927 | GEO

microRNAs associated with bromocriptine-treated prolactinomas

Project description:Little is known about the function of microRNA in prolactinomas treated with bromocriptine. The aim of the study was to explore the microRNAs associated with bromocriptine-treated prolactinomas. Six samples are analyzed, no replicates are included.A common reference consisted of a mix of the products that was spotted on the array.

2010-09-01 | E-GEOD-23927 | biostudies-arrayexpress

Natural and molecular history of prolactinoma: insights from a Prlr -/- mouse model

Project description:Mouse models of prolactinoma can be useful to better understand molecular mechanisms involved in abnormal lactotroph cell proliferation and secretion. We have previously developed a prolactin receptor deficient (Prlr -/-) mouse, in which Prlr -/- females develop large secreting prolactinomas from 12 months of age with a penetrance of 100%, mimicking human aggressive densely granulated macroprolactinoma, a highly secreting subtype.

2018-02-21 | GSE100334 | GEO

Human blood monocytes scRNAseq

Project description:Human blood monocytes scRNAseq

| PRJNA871108 | ENA

Integrative miRnome and transcriptome analysis in human malignant prolactin pituitary tumors identify miR-183 as driving gene for tumor progression to malignancy.

Project description:miRNAs expression is known to be deregulated in many types of cancer leading to suspect them implication in crucial steps occurring during tumor progression and maybe as potential driving genes. In this study we tried to decipher the place of miRNA in the hierarchical events cascade occurring in prolactinoma-tumours progression toward malignancy by using an integrative genomic approach performed on the same samples associating global miRNA expression, transcriptomic, DNA structure and methylation analyses. By this approach, we observed the down-regulation of 3 miRNAs (miR-183, miR-98, and miR-744) in A vs. NA tumors. MiR-98 and miR-744 were demonstrated to regulate respectively E2F2 and TGFB1 which are up-regulated in the A vs. NA prolactinomas. Moreover we demonstrated that KIAA0101 is a new target of miR-183 and that miR-183 is regulated by the transcription factor ETS2. KIAA0101 is up-regulated in the A vs. NA prolactinomas. KIAA0101, E2F2 and TGFB1 are interconnected in a pathway controlling cell proliferation and invasion that is over-activated in A PRL tumors. Thus the down-regulation of these three miRNAs is involved in the tumoral progression of human prolactinoma towards aggressiveness. The integrative genomic approach used here allowed us to propose a model of PRL tumoral progression towards aggressiveness. Moreover it revealed the potential of integrative genomic strategy applied in the same human tumors to identify the molecular mechanisms responsible for tumor progression even from a small cohort of patients.

2015-05-01 | GSE46294 | GEO

Single cell-derived spheroids capture the self-renewing subpopulations of metastatic ovarian cancer

Project description:scRNAseq data from human patients and generated colture

2024-01-30 | E-MTAB-11207 | biostudies-arrayexpress

Homo sapiens

Project description:microRNAs associated with bromocriptine-treated prolactinomas

| PRJNA130323 | ENA

Mapping the Human Colon Using Single Cell Sequencing

Project description:The overall purpose of this study is to describe the cellular composition of the human colon and its gene expression using scRNAseq and scATACseq methods. This will potentially provide is with a detailed map of the colon aiding our understanding of how diseases of the colon develop as well as the colons influence on systemic diseases such as type II diabetes.

| 2401272 | ecrin-mdr-crc

p300-Mediated Histone H3K18 Lactylation Promotes Mitochondrial ROS Accumulation via Mitophagy Inhibition to Potentiate Dopamine Agonists Efficacy in Prolactinomas [CUT&Tag]

Project description:Prolactinomas are the most common functional pituitary adenomas, with dopamine receptor agonists (DAs) as the first-line therapy. However, 10–30% of patients develop DA resistance, and the underlying mechanisms remain incompletely elucidated.Clinical samples were collected to analyze p300 expression. Experiments including immunofluorescence, immunohistochemistry, gene editing, Western blot, co-immunoprecipitation, ChIP-qPCR, RNA/CUT&Tag sequencing, flow cytometry, Seahorse assay, and mass spectrometry were performed to explore the synergistic anti-tumor mechanism of upregulating/activating p300 combined with DAs. DAs downregulated p300 by inhibiting the cAMP-PKA-CREB pathway. Upregulating/activating p300 synergized with DAs to promote mitochondrial ROS elevation and cell apoptosis, which depends on p300’s histone acetyltransferase (HAT) domain mediating histone H3 lysine 18 lactylation (H3K18la). p300-mediated H3K18la significantly promoted intracellular ROS accumulation by upregulating Ndufs7 (promoting mitochondrial ROS production) and Washc1 (inhibiting mitophagy). YF-2, a p300 HAT domain activator, exhibited synergistic anti-tumor activity with DAs.This study reveals the p300-H3K18la- mitophagy-ROS regulatory axis, providing a new target and strategy for treating DA-resistant prolactinomas.

2026-03-11 | GSE313568 | GEO

scRNAseq of human foetal cochleas

Project description:scRNAseq of human foetal cochleas

| PRJEB75573 | ENA